Neither vaginal nor buccal administration of 800 μg misoprostol alters mucosal and systemic immune activation or the cervicovaginal microbiome: a pilot study

by Kalams, Spyros A., Rogers, Lisa M., Smith, Rita M., Barnett, Louise, Crumbo, Katie, Sumner, Shonda, Prashad, Naomi, Rybczyk, Kyle, Milne, Ginger, Dowd, Scot E., Chong, Erica, Winikoff, Beverly, Aronoff, David M.
Published in Eur J Contracept Reprod Health Care (2016)

Immunization with Cocktail of HIV-Derived Peptides in Montanide ISA-51 Is Immunogenic, but Causes Sterile Abscesses and Unacceptable Reactogenicity

by Graham, Barney S., McElrath, M. Juliana, Keefer, Michael C., Rybczyk, Kyle, Berger, David, Weinhold, Kent J., Ottinger, Janet, Ferarri, Guido, Montefiori, David C., Stablein, Don, Smith, Carol, Ginsberg, Richard, Eldridge, John, Duerr, Ann, Fast, Pat, Haynes, Barton F.
Published 2010

Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery

by Kalams, Spyros A., Parker, Scott D., Elizaga, Marnie, Metch, Barbara, Edupuganti, Srilatha, Hural, John, De Rosa, Stephen, Carter, Donald K., Rybczyk, Kyle, Frank, Ian, Fuchs, Jonathan, Koblin, Beryl, Kim, Denny H., Joseph, Patrice, Keefer, Michael C., Baden, Lindsey R., Eldridge, John, Boyer, Jean, Sherwat, Adam, Cardinali, Massimo, Allen, Mary, Pensiero, Michael, Butler, Chris, Khan, Amir S., Yan, Jian, Sardesai, Niranjan Y., Kublin, James G., Weiner, David B.
Published 2013